Use of medications for cardiovascular disease and type 2 diabetes mellitus is reduced after bariatric surgery for weight management in patients with severe obesity

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.479, 2005-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H.   Kennedy F.P.   Garratt K.N.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Atorvastatin: A Review of its Use in the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus

By Croom Katherine F.   Plosker Greg L.  

Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. : 137-152

Adis International

Access to resources Recommend Favorite

Future anti-inflammatory metabolic and cardiovascular management of Type 2 diabetes mellitus

By Laight David W  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 11, 2003-11 ,pp. : 1683-1689

Informa Healthcare

Access to resources Recommend Favorite

Influence of Bariatric Surgery on the Expression of Nesfatin-1 in Rats with Type 2 Diabetes Mellitus

By  

Current Pharmaceutical Design, Vol. 21, Iss. 11, 2015-02 ,pp. : 1464-1471

Bentham Science Publishers

Access to resources Recommend Favorite

Bariatric surgery or medicine for type 2 diabetes?

By Doggrell Sheila A   Chan Vincent  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2249-2253

Informa Healthcare

Access to resources Recommend Favorite